Inogen Appoints Myomo Co-Founder Mira Sahney to Board for Enhanced Respiratory Care Leadership
- Mira Kirti Sahney, co-founder of Myomo, joins Inogen's Board of Directors effective January 31, 2025.
- Sahney's expertise in medical device leadership will enhance Inogen's initiatives in respiratory care.
- Inogen aims to leverage Sahney’s background to improve patient outcomes and drive future initiatives.
Inogen Appoints Mira Kirti Sahney to Board of Directors, Strengthening Leadership in Respiratory Care
Inogen, Inc., a leading player in the medical technology sector focused on respiratory care, announces the appointment of Mira Kirti Sahney to its Board of Directors, effective January 31, 2025. This strategic appointment follows the retirement of Tom West, who has been on the board since April 2023 and will step down on January 30, 2025. Elizabeth Mora, the Chairperson of the Board, expresses enthusiasm about Sahney's extensive managerial and operational experience, which is expected to enhance Inogen's leadership as the company seeks to solidify its position in the global respiratory care market.
Sahney's impressive credentials include significant leadership roles in prominent medical device companies. Before her appointment at Inogen, she served as President of the Pelvic Health Operating Unit at Medtronic and held various executive positions at Hyalex Orthopaedics and Smith + Nephew. Additionally, Sahney co-founded Myomo, Inc., a company specialized in wearable medical robotics, reflecting her deep understanding of innovation in healthcare technology. Her educational background is equally notable; she earned a Bachelor’s degree in Mechanical Engineering from the University of Michigan and holds multiple advanced degrees from Stanford University and MIT, including an MBA.
In her statement regarding the appointment, Sahney expresses gratitude for the opportunity to join Inogen's board during a critical phase for the company. She emphasizes her commitment to enhancing shareholder value and improving patient care solutions. As a new board member, she will also contribute to the Compliance and Nominating and Governance Committees, which play vital roles in maintaining ethical standards and effective governance within the organization. Inogen continues to focus on developing and marketing advanced respiratory therapy devices, reinforcing its commitment to supporting patients with respiratory conditions.
Inogen's ongoing mission to provide innovative solutions in respiratory care positions the company to benefit from Sahney's expertise and insights. With a growing emphasis on enhancing leadership capabilities, Inogen aims to leverage Sahney’s background to drive future initiatives and improve patient outcomes in the rapidly evolving respiratory care landscape. As the company navigates its next chapter, the integration of Sahney’s extensive experience signals a proactive approach to addressing the challenges and opportunities within the healthcare sector.